Search

OBJETIVO: Investigar a ocorrência e os fatores de risco para morbidade depressiva em uma amostra de 38 pacientes ambulatoriais com neurocisticercose. MÉTODOS: O diagnóstico psiquiátrico baseou-se nos exames do estado mental atual e pregresso, respectivamente obtidos pelas entrevistas estruturadas do PSE-9 e SADS-L; as funções cognitivas foram avaliadas pelo MMS e pelo roteiro de Strub & Black (Mental Status Examination). RESULTADOS: Transtornos depressivos foram o achado psiquiátrico mais frequente (63,1%) entre os pacientes da amostra. Destes, 20 (52,6%) mostravam-se deprimidos no momento da avaliação e 4 apresentaram depressão no passado. Entre os pacientes deprimidos, 16 preencheram critérios diagnósticos do DSM-III-R para transtorno orgânico do humor (k = 0,4). Antecedentes pessoais de depressão (p = 0,006), sinais de atividade da doença (p = 0,044) e ocorrência de hipertensão intracraniana (p=0,065) foram os parâmetros clínicos que se correlacionaram com a presença de depressão. CONCLUSÕES: Tais achados, aliados à ausência de predomínio do sexo feminino entre os casos de depressão, sugerem etiologia orgânica. Os autores discutem essas observações à luz da literatura sobre outros transtornos mentais orgânicos.

thalam-ic brain abscess who did not improve with systemic treatment with sulphonamides and amphotericin-B but was cured with repeated stereotatic intralesional instilla-tion of amphothericin-B.CASE A 32 year-old man was admitted with 2 months history of headache and pro-gressive blurring of the vision in both eyes, weakness of right limbs and somno-lence. His general physical examination was normal. However, he was disorient-ed and presented right grade III complete spastic hemiparesis, bilateral papillede-ma and right homonimous hemianopsia. The white blood cell count, the erythro-cyte sedimentation rate and the chest and skull X-rays were normal. The CT-scan of the brain revealed a cystic mass with a nar -row wall in the left thalamus (Fig 1A). The CSF contained 3 leucocytes/mm

É crescente a incidência da neurotoxoplasmose em virtude do alastramento da AIDS. Seu tratamento, em geral, mostra bons resultados com a associação sulfadiazina-pirimetamina. Neste estudo são apresentados os resultados obtidos com a associação sulfa-metoxazol-trimetoprim. Conclui-se que ambos os esquemas apresentam resultados superponíveis. Toxoplasmosis is the most frequent parasitic infection of the CNS in the immunocompromised host. When promptly treated with the sulfadiazine-pyrimethamine combination patients with cerebral toxoplasmosis characteristically respond with clear clinical and CT improvement within 1-2 weeks. We report the results achieved with the combination sulfamethoxazole-trimethoprim, and conclude that both combinations have similar effects in the treatment of CNS toxoplasmosis.

Three hundred land fifty seven computed tomography (CT) from 100 different patients with neurocysticercosis (NC) were studied between 1979 and 1988. All patients were treated with praziquantel (PZQ). A new classification attempting to recognize the CT evolution profile in NC as well as assigning a possible link between CT findings and biological conditions of cysts is evaluated. It was possible to conclude that: intact cysts remain unchanged in consecutive CTs by 11 months and exhibit signs of degeneration in about 18 months after PZQ drug therapy; degenerating cysts can be detected by 10.5 months, disappear in 11 months and become nodular calcifications in about 25 months. Therefore, a time period of at least 36 months can be estimated for the complete evolution profile of cysts in the brain parenchyma.

HTLV-l antibodies were investigated in serum and in CSF of 150 patients with neurologic disorders mainly myelopathies. The patients were considered into three groups according to the possible relationship of their disease to the presence of HTLV-l antibodies: no relationship risk (control group), occasional risk group, and possible risk group. In this latter are 56 patients with crural spastic paraparesis or paraplegia of unknown etiology (SP). HTLV-l antibodies were tested by the passive particle-agglutination method for anti-ATLA antibody detection. The search was negative in all patients of the control group, and positive (serum and/or CSF) in 16.5% of the patients from the second group and in 55.4% of the SP patients group. Clinical patterns in SP cases with HTLV-l antibodies were those of tropical spastic paraparesis (TSP). CSF patterns considered (cytology, protein content and gamma-globulins rate) were different between TSP group with HTLV-l antibodies in CSF and SP group with no HTLV-l antibodies detection either in serum or in CSF. The difference was significant. Results of this investigation confirm the high incidence of TSP in Brazil, and bring additional indication for searching HTLV-l antibodies in the CSF.

OBJETIVO: Analisar os resultados obtidos pela ressonância magnética (RM) e eletroneuromiografia (ENMG) em pacientes com diagnóstico de esquistossomose medular (EM). MÉTODO: Foram analisadas 18 RM da coluna vertebral tóraco-lombar e 24 ENMG dos membros superiores e inferiores de pacientes com diagnóstico definido ou altamente provável de EM nas suas formas clínicas mielorradiculítica e mielítica. RESULTADOS: Entre as 18 RM realizadas, 16 (88,8%), mostraram alterações caracterizadas por imagens hipointensas em aquisições pesadas em T1, hiperintensas em T2, com captação heterogênea do contraste gadolínico e/ou realce das meninges e cauda equina. Entre as 24 ENMG, 23 (95,8%) mostraram quadro de multirradiculopatia bilateral das raízes nervosas L2, L3, L4, L5, S1, S2, assimétrico em 10 casos (41,6%). CONCLUSÃO: A RM e a ENM demonstraram ser exames úteis para o diagnóstico da EM ao revelarem anormalidades que se repetiram sob um determinado padrão em 88,8% e 95,8% dos casos, respectivamente. Apesar de não terem especificidade para a EM, estes procedimentos devem ser realizados rotineiramente com o objetivo de fortalecer o diagnóstico presuntivo desta doença. OBJECTIVE: To analyze the usefulness of magnetic resonance imaging MRI and electroneuromyography (ENMG) in the diagnosis of schistosomiasis of the spinal cord (SSC). METHOD: 18 MRI of the thoracolumbar spine and 24 ENMG of the upper and lower limbs were carried out on patients with a definite diagnosis of SSC in the clinical forms of myeloradiculitis or thoracic transverse myelitis. RESULTS: Of the 18 MRI carried out, 16 (88.8%) showed abnormalities on T1 and T2 weighted images and heterogenous pattern of enhancement with contrast material injection. Of the 24 ENMG, 23 (95.8%) showed a feature of bilateral multiradiculopathy of roots L2, L3, L4, L5, S1, S2, asymmetric in 10 cases (41.6%), characterized by signs of denervation in the lumbar paraspinal musculature and long duration polyphasic potentials in increased proportion, as well decrease of the recruitment of motor units. CONCLUSION: In spite of the non-specificity of both exams, the MRI and the ENMG showed to be useful for the diagnosis of SSC, by revealing abnormalities that repeated in 88.8% and 95.8% of the cases, respectively.

O objetivo deste estudo é analisar dados clínicos e laboratoriais de 80 casos de esquistossomose medular (EM) que possam contribuir para melhorar o diagnóstico e tratamento dessa doença. Em 59 pacientes o estudo foi de maneira prospectiva, em 79 pacientes o diagnóstico foi catalogado como altamente provável, presuntivo, baseado em critérios clínico e laboratoriais. Em um paciente houve confirmação anatomo-patológica. Houve predominância do sexo masculino (63,7%), faixa etária entre 21 e 40 anos (63,7%), procedência nordestina (85%), trabalhador em construção civil (31,2%), esforço abdominal prévio (57,5%), início subagudo (61,2%), forma clínica mielorradiculítica e lesão no cone medular e cauda equina (72,5%). O estudo do líquido cefaloraquidiano mostrou pleocitose e taxas elevadas de proteínas em 100% dos casos, da gamaglobulina em 76.5%, positividade de reações imunológicas específicas (imunofluorescência e/ou ELISA) em 100% dos casos (titulo médio de 1/16 e 61u/dl, respectivamente). Costicosteróides e drogas esquistossomicidas foram administrados em todos os pacientes com evolução satisfatória em 80% dos casos. To outline through cinical-laboratorial analysis a profile of schistosomiasis of the spinal cord (SSC) that contributes to the diagnosis and treatment of this disease. 80 patients were studied (59 prospectively), and epidemiological, clinical,laboratorial, treatment and outcome data extracted. In 79 patients the diagnosis was presumptive and obeyed rigorous criteria. There was a predominance of male sex (68.7%), age group from 21 to 40 years (63.7%), Northeasterners (85%), building construction workers (31.2%), previous abdominal effort (57.5%), subacute beginning (61.2%), myeloradiculitis form and lesion in conus and cauda equina (72.5%). Cerebral spinal fluid showed lymphomononuclear pleocytosis and protein increase in 100% of the cases as well as gamma globulin in 76.5%, positiveness of immunofluorescence reaction and/or ELISA for schistosomiasis in 100% of the cases with average titles of 1/16 and 61 u/dl, respectively. Corticosteroids and antischistosomal drugs were given to all patients with a satisfactory outcome in 80% of the cases. We emphasize the importance of a precocious treatment to avoid irreversible deficits such as paraplegia or sexual impotence.

We analyzed cerebrospinal fluid (CSF) and blood serum from 55 patients with neurocysticercosis (NC) at different clinical stages. According to inflammatory activity in the CSF, three stages were identified: (1) reactive, when there was at least an increase in the number of cells; (2) weakly reactive, when significant alterations were found in the CSF, including an increase in gamma globulins, albeit without hypercytosis; (3) non-reactive, when there was neither hypercytosis nor increase in gamma globulins. Nineteen patients had the reactive form; 18 had the weakly reactive form; 18 displayed the non-reactive form. Local immunoproduction was intense in the reactive group, moderate in the weakly reactive group, and absent in the non-reactive group. The specific antibody index was raised in approximately 2/3 of patients with the reactive form, 2/3 in those with the weakly reactive form, and 1/3 in those with the non-reactive form. In conclusion: (1) the classical CSF syndrome in NC can present both in complete and partial modes; (2) local immunoproduction can occur in weakly reactive forms; (3) a raised specific antibody index can occur in the absence of an inflammatory reaction in the CSF. Analisamos o líquido cefalorraqueano (LCR) e o soro sanguíneo de 55 pacientes com neurocisticercose (NC) em diversas fases de evolução. De acordo com a atividade inflamatória no LCR, foram consideradas três formas: (1) reativa, quando havia pelo menos aumento do número de células; (2) fracamente reativa, quando havia alterações no LCR, incluindo aumento de globulinas gama, mas sem pleocitose; (3) não reativa, quando não havia pleocitose nem aumento de globulinas gama. Dezenove pacientes apresentavam a forma reativa, 18 a forma fracamente reativa, 18 a não reativa. O índice de anticorpos específicos estava aumentado em cerca de 2/3 dos pacientes das formas reativa, em 2/3 na forma fracamente reativa e em 1/3 na forma não reativa. Conclusão: (1) a síndrome do LCR na NC pode apresentar-se tanto de modo completo quanto de modo parcial; (2) imunoprodução local de anticorpos específicos pode ocorrer também em pacientes sem aumento de células; (3) índice de anticorpos específicos elevado pode ocorrer mesmo na ausência de reação inflamatória no LCR.

Neurocysticercosis is an endemic disease in some developing countries. It has pleomorfic clinical and imaging findings, which are variable from patient to patient. In this preliminary note, we studied the magnetic resonance (MR) diffusion-weighted images (DWI) of sixteen patients presenting with cystic lesions of this disease diagnosed by clinical and laboratorial findings. All the lesions had hypointense signal and the similar apparent diffusion coeficient (ADC) values as the cerebrospinal fluid (CSF). Neurocisticercose é doença endêmica em alguns países em desenvolvimento. Ela apresenta aspectos clínicos e de imagem que variam em cada paciente. Nesta nota preliminar expomos um estudo utilizando imagens ponderadas em difusão em dezesseis pacientes que apresentavam lesões císticas da neurocisticercose comprovada clínica e laboratorialmente. Todas as lesões examinadas apresentaram hipo-sinal com intensidade de sinal e valores de coeficiente de difusão aparente (CDA) similares ao do líquido cefalorraquiano.

OBJECTIVE: To determine the frequency and features of psychiatric morbidity in a cross section of 38 outpatients with neurocysticercosis. METHODS: Diagnosis of neurocysticercosis was established by CT, MRI, and CSF analysis. Psychiatric diagnoses were made by using the present state examination and the schedule for affective disorders and schizophrenia-lifetime version; cognitive state was assessed by mini mental state examination and Strub and Black's mental status examination. RESULTS: Signs of psychiatric disease and cognitive decline were found in 65.8 and 87.5% of the cases respectively. Depression was the most frequent psychiatric diagnosis (52.6%) and 14.2% of the patients were psychotic. Active disease and intracranial hypertension were associated with higher psychiatric morbidity, and previous history of mood disorders was strongly related to current depression. Other variables, such as number and type of brain lesions, severity of neuropsychological deficits, epilepsy, and use of steroids did not correlate with mental disturbances in this sample. CONCLUSIONS: Psychiatric abnormalities, particularly depression syndromes, are frequent in patients with neurocysticercosis. Although regarded as a rare cause of dementia, mild cognitive impairment may be a much more prevalent neuropsychological feature of patients with neurocysticercosis. The extent to which organic mechanisms related to brain lesions may underlie the mental changes is yet unclear, although the similar sex distribution of patients with and without depression, as well as the above mentioned correlations, provide further evidence of the part played by organic factors in the cause of these syndromes.

Foram estudados oito pacientes com histoplasmose do sistema nervoso central, nenhum deles com sinais clínicos ou laboratoriais de imunodepressão. O tempo de doença por ocasião do diagnóstico variava entre 6 e 108 meses (mediana 36 meses). Principais sinais e sintomas encontrados: síndrome de hipertensão intracraniana, em 6 pacientes; déficit de memória, em 4; confusão mental, em 4; convulsões, em 2; paraparesia ou paraplegia crural, em 2; incontinência urinária, em 2; impotência sexual, em 1. A forma meningoencefalítica foi encontrada em 6 pacientes e a granulomatosa, em 2. O diagnóstico foi feito: por biópsia em 1 caso; por necrópsia, em 2; através de cultura do sedimento do LCR em meio de Sa-bounaud, em 1; através da detecção de anticorpos a, Histoplasma capsulatum no LCR, em 5. Foi observada profunda discrepância entre as alterações detectadas ao exame de LCR (intensas, com elementos de fase aguda mesclados a elementos de fase crônica) e o quadro clínico por ocasião do diagnóstico (pacientes em geral oligossintomáticos). Clinical approach has been made in eight patients with histoplasmosis of the central nervous system. All patients had no evidence of immunodepression. Time disease at diagnosis ranged from 6 to 108 months (median 36 months). Main signs and symptoms were: intracranial hypertension in 6 patients; impairment of memory in 4; confusion in 4; seizures in 2; urinary incontinence in 2; sexual impotency in 1. Meningoencephalitic form was present in 6 patients, while the granulomatous form was found in 2. Diagnostic confirmation was based on: biopsy, in 1 case; necropsy, in 2 cases; cerebrospinal fluid (CSF) sediment culture, in 1; detection of antibodies against Histoplasma capsulatum in the CSF, in 5 ciases. There was, in all patients, an expresive difference between CSF alterations (intense, merging acute and chronic phase elements) and clinical symptomatology (patients in general oligosymptomatic).

Foi estudado sistematizadamente o LCR de 50 pacientes com AIDS que apresentavam sintomatologia passível de ser atribuída a comprometimento do SNC. Somente 5 apresentavam o quadro do LCR dentro dos limites normais. Em um, ocorriam células neoplásicas (linfoma); em 10, Cryptococcus neoformans; reações imunológicas foram positivas para sífilis em três e para toxoplasmose em 4. Um dos casos de criptococose apresentava simultaneamente toxoplasmose e desenvolveu sífilis, ulteriormente. Em outro dos casos de criptococose durante a evolução surgiram leveduras do gênero Candida. Considerando os achados, são discutidos quanto ao LCR aspectos: da reação inflamatoria na vigência de imunodeficiência; do comprometimento da BHE; do comprometimento do SNC; de efeitos de massa que podem ocorrer, como aqueles provocados por tumores e granulomas. Cerebrospinal fluid (CSF) was analysed in 50 AIDS patients in this investigation. CSF analysis included: pressure, aspect, colour, cytology (cell number, cytomorphology, and lymphocyte subpopulations), proteins concentration and their electrophoretic distribution, chloride and glcosis concentration, GOT and LDH activity, immunology for cysticercosis, syphilis and toxoplasmosis, bacteriology, and mycological examinations (direct, cultures, Cryptococcus neoformans antigen test). Diagnostic changes were: lymphoma cells in one patient, cryptococcosis in 10, toxoplasmosis in 4, candidiasis in 1, and syphilis in 3. Cryptococcosis occurred in association with toxoplasmosis in one patient who developed syphilis in the follow-up; oligoclonal distribution of gamma globulins ocurred in this case. In another case of cryptococcosis, candidiasis appeared during the course of the disease. Changes in the CSF composition observed are discussed in order to evaluate: aspects of CSF inflammatory response in report to immunodeficiency; blood-brain barrier involvement; CNS damage; intracranial mass effects.

São apresentados 18 casos de criptococose do sistema nervoso central e são tecidos comentários a propósito do tratamento e das dificuldades respectivas, especialmente em pacientes transplantados renais. É chamada a atenção para as eventuais possibilidades de nova droga introduzida para o tratamento da afecção e empregada em um dos casos relatados, o miconazole. Results obtained in the treatment of cryptococcosis of the central nervous system with amphotericin-B, 5-fluorocytosine and miconazole are evaluated. The evaluation is based upon 18 cases. Emphasis is given to data pertinent to aspects proper to 7 of them, submitted to chronic immunossupressive treatment due to previous kidney transplantation. Side effects varied from case to case in the patients submitted to amphotericin-B and 5-fluorocytosine treatment. The intrathecal and the intraventricular administration of amphotericin-B was followed by complications of several types. Miconazole was used in one case. Its intravenous and its intrathecal administration did not provoke remarkable side effects.

Registro de dois casos de criptococose do sistema nervoso central, em um deles associada a candidíase. Em ambos foram utilizados no tratamento anfotericina-B e 5-fluorocitosina. Em função dos resultados obtidos são feitas considerações quanto à utilidade de cada uma das drogas no tratamento da criptococose, bem como quanto ao uso associado de ambas. Two cases of cryptococcosis of the central nervous system are reported. The treatment was based on the association of amphotericin-B with 5-fluorocytosine. Details on the therapeutic proprieties of these drugs are discussed considering the results obtained. Amphotericin-B was administered intravenously and intrathecally in the two cases. The total amount of amphotericin administered intravenously in the first case was 5.375 mgm, and the oral doses of 5-fluorocytosine were not superior to 100 mgm/kg/of body weight. This patient died 130 days after the first symptoms of the disease. The second patient had been submitted previously to kidney transplantation after bilateral nephrectomy, and inmunossupressive drugs were administered to him since then. Candidiasis and cryptococcosis of the central nervous system developped two years later. 5-fluorocytosine was administered orally (200 mgm/kg of body weight) and amphotericin-B. The total amount of this drug administered intravenously was 2.00 mgm. There was complete clinical and laboratory remission of the mycoses in this case.

Cerebrospinal fluid (CSF) and serum samples of 10 patients with neurocysticercosis under treatment by praziquantel were studied in four occasions: before treatment (day 0) and during treatment on three occasions (days 1, 7 and 21). The immunological reaction analyzed were: ELISA-G and ELISA-M; immunofluorescence-G and immunofluorescence-M; complement fixation. The changes and the variability of results observed through these reactions in this study bring new data that confirm neuroimmunological findings already described in the disease. Acute phase response was found in CSF in 6 cases and only in one case in serum by ELISA-M and immunofluorescence-M. ELISA-G in CSF and serum showed a better sensitivity than the other reactions for diagnosis and for follow-up. Emphasis is given to the importance of the simultaneous realization of several immunological reactions in CSF and serum in patients with neurocysticercosis.

É relatado caso de paciente com neurossífilis que apresentou deterioração clínica e persistência de alterações do líquido cefalorraqueano após repetidas tentativas terapêuticas com altas doses de penicilina. Tratamento com cloranfenicol resultou em estabilização do quadro clínico e melhora laboratorial. A case of neurosyphilis that got worse despite several therapeutical trials with high doses of penicillin is described. The clinical condition was stabilized and cerebrospinal fluid data normalized following treatment with chloramphenicol

A case of primary amebic meningoencephalomyelitis due to Naegleria sp observed in a 14 years old boy is reported. Symptoms due to myelitis at the dorsal level assumed ascending character during the first days of disease. Manifestations due to encephalic involvemente were discrete. Cerebrospinal fluid changes were marked by pleocytosis, and the eosinophil cells participation in the cytomorphological profile was persitently high. Amphotericin-B was used intravenously (25 mgm/day) until 1,500 mgm of total dosis. Remission of encephalitis manifestations was prompt, as well as of meningeal signs. Cerebrospinal fluid changes disappeared progressively. Sensitive-motor changes due to spinal cord involvement persisted as permanent sequelae. Naegleria sp., was isolated from the cerebrospinal fluid in the acute stage of the disease, as well as, from the water of a lagoon where the patient used to swim.

Para avaliar a informação que pode ser obtida mediante o estudo do líquido cefalorraqueano (LCR) em acidentes vasculares cerebrais (AVC) foram analisados os dados de 1500 casos. Três tipos fundamentais de AVC podem ser considerados do ponto de vista do LCR: AVC LCR tipo 1, sem hemácias e sem xantocromia (incolor); AVC LCR tipo 2, sem hemácias e com xantocromia; AVC LCR tipo 3, com hemácias e com xantocromia. Os dados quanto a cada grupo são discutidos bem como suas correlações. O papel de alterações metabólicas sistêmicas, da barreira hêmato-encefálica e do comprometimento do parênquima do sistema nervoso central são discutidos na interpretação dos achados. Considerações finais são feitas quanto à utilidade do estudo do LCR em AVC frente a avanços em outras técnicas de investigação, como as de neuroimagem. In order to evaluate information on acute stroke through the study of cerebrospinal fluid (CSF) data em 1500 patients were analysed in the first 48 hours following stroke. Cases were distributed in three groups according to CSF basic findings: type 1, CSF without erythrocytes and without xanthochromy; type 2, CSF without erythrocytes and with xanthochromy; tipe 3, CSF with erythrocytes and with xanthocromy. Data on each type are discussed as well as correlation findings. Systemic metabolic disturbances, blood-brain barrier impairment and central nervous system lesions are discussed as to the role they have in CSF changes observed in stroke. Indication of CSF exam in stroke is reviewed taking into account progress in neuroimaging techniques.

Registro de caso de mucormicose órbito-rino-cerebral em paciente diabético e em cetoacidose, com quadro clínico característico e que apresentou boa evolução graças ao tratamento iniciado precocemente. É feito um resumo dos principais registros da literatura a respeito da patologia. The case of a 15 years old white man, diabetic in cetoacidosis, with a orbit-rhino-cerebral phycomycosis is reported. The illness had an acute onset and the treatment was iniciated early with Amphotericin-B and unilateral osteotomy of maxillary and ethmoidal sinus. With this treatment the patient did well with residuals of ophtalmoplegia and amaurosis on the right. Interesting investigation aspects are the occluded internal carotid on the same side of the affected orbit and the CAT-SCAN finding of moderated ventricular dilatation (two month after hospital admission). Mycology, pathophysiology, histopathology, clinical aspects, diagnosis and therapy are discussed, comparing the findings of this case with available literature. An increased number of survivors can be expected with earlier recognition and more aggressive therapy. Treatment of the underlying debilitating disease, Amphotericin-B and surgical debridement of necrotic tissue, are frequently necessary such as observed in the case reported. The favorable results ootaineü with the proposed managment are stressed.

Avaliação dos resultados de estudo prospectivo da evolução de 100 pacientes com neurocisticercose (NC) aos quais foi administrado praziquantel (PZQ). A evolução foi avaliada por mais de dois anos em 63 casos (máximo 118 meses) e levou em conta os aspectos clínicos, da TC e do LCR. Resultados favoráveis predominaram (72,5%), particularmente entre aqueles pacientes nos quais as manifestações clínicas da NC não eram acompanhadas de hipertensão intracraniana de caráter permanente e progressivo. Os resultados obtidos são favoráveis à indicação do PZQ em pacientes com NC.

In 10 patients with neurocysticercosis (NC), an assessment was made of the praziquantel (PZQ) concentration in the cerebrospinal fluid (CSF), in non-deproteinized serum and in protein-free serum: before administration of the drug and the 1st., 7th. and 21st. days of oral administration (50mg/kg/day during 21 days). Samples of CSF and blood were collected three hours after the last administration of the daily total dosage, on the 1st. and 21st days; and from 2 to 6 hours after drug administration on the 7th. day. The total daily dosage was distributed into three equal parts of 1/3 each, with a 4 hours' interval between intakes, except in the last 5 cases, who on the 21st. day only were given the total daily dosage on a single administration. Results have shown dispersion in serum concentrations, which are similar to those seen in normal subjects as recorded in literature. There is a correlation between PZQ levels in the CSF and in the serum, the latter being very close to those found in protein-free serum fraction. The statistical treatment of results allowed the following considerations: PZQ concentrations in the CSF and in the protein free serum are in balance from the pharmacodynamic standpoint on the first day; this balance is maintained up to the 21st. day although at different levels from those seen on the 7th. day; on the 21st. day PZQ contents in CSF goes back to its similar values as recorded on the 1st. day, and this suggests that the participation of drug interaction factors has been reduced to non-significant levels. However, several factors can influence PZQ concentration in CSF, as absorption rate, liver first-pass effect and blood-brain barrier changes, and individual dose should be established for each patient based on drug concentration monitoring in the serum and/or in the CSF. Em 10 pacientes com neurocisticercose (NC) foi determinada a concentração de praziquantel (PZQ) no líquido cefalorraqueano (LCR), no soro não desproteinizado e no soro desproteinizado: antes do início do emprego da droga e nos dias primeiro, sétimo e 21º de administração oral da droga (50mg/kg/dia durante 21 dias). As amostras de LCR e de sangue foram colhidas três horas após a administração da dose diária nos dias 1 e 21 e de duas a 6 horas após no dia 7; a dose total diária foi repartida em três porções semelhantes de 1/3 cada, com intervalo de 4 horas entre cada tomada, exceto nos 5 últimos casos que apenas no dia 21 receberam a dose total diária em uma só tomada. Os resultados mostraram haver dispersão das concentrações séricas e que estas são semelhantes às observadas em pessoas normais, fato já registrado na literatura. Há correlação entre os níveis de PZQ no LCR e no soro, sendo estes próximos àqueles observados no soro desproteinizado, isto é, próximo à fração sérica livre. O tratamento estatístico dos resultados permite considerar que: as concentrações de PZQ no LCR e no soro desproteinizado estão em equilíbrio, do ponto de vista farmacodinâmico, desde o primeiro dia; este equilíbrio persiste até o 21º dia, conquanto em níveis diferentes dos registrados no sétimo dia; no dia 21º os teores de PZQ no LCR retornam a valores semelhantes aos registrados para o primeiro dia, sugerindo haver sido reduzida a níveis não significativos a participação de elementos de interação com a droga. Contudo, fatores que influenciam na concentração de PZQ no LCR, como aqueles ligados à absorção da droga, sua metabolização no fígado e a sua passagem através da barreira hêmato-encefálica, que pode estar alterada pela doença, devem ser levados em conta e permitem recomendar o estabelecimento de dose individual para cada paciente mediante monitorização da concentração real alcançada no soro e/ou no LCR.

É relatado o caso de um paciente de 14 anos, do sexo masculino, com esclerose cerebral difusa precedida em 7 anos de sinais de insuficiência do córtex supra-renal, com antecedentes familiares. Clinicamente a doença é caracterizada por deterioração mental, distúrbios da marcha e da visão, associados com insuficiência do córtex supra-renal. Confirmando os dados da literatura, em nosso caso o estudo anátomo-patológico revelou desmielinização e gliose difusa na substância branca cerebral, poupando as fibras subcorticais. Células inflamatórias são comuns e têm distribuição perivascular. Na zona fasciculada e reticular da supra-renal, células "balonadas" são evidentes, muitas delas apresentando citoplasma vacuolizado e com estriações. Inclusões lipídicas similares têm sido encontradas nas células de Schwann dos nervos periféricos e dos testículos. Os achados são comparados com vinte casos da literatura. The case of a 14-year-old boy with "diffuse cerebral sclerosis", preceded by signs of primary adrenal cortical insufficiency for 7 years with familiar antecedents is reported. This disorder, named adrenoleukodystrophy, has a sex-lin(ed recessive inheritance. The clinical picture is characterized by mental deterioration, gait disturbances, visual impairment, associated with primary adrenal cortical insufficiency. Confirming the data from literature, in our case the pathological study showed myelin degeneration and diffuse gliosis in the cerebral white matter, with no involvement of subcortical fibers. Inflammatory cells are common, and have a perivascular distribution. In the fasciculata and reticular zones of the adrenal gland, "baloon-shaped" cells are evident, most of them presenting a vacuolized and striated cytoplasm. Similar lipidic inclusions have been found in the Schwann cells of the peripheral nerves and testis. The findings are compared with twenty cases from the literature.

In this preliminary report the authors present the finding of a high prevalence (37.5%) of seropositivity of antibodies to HTLV-I tested by Western blotting in a sample of 16 Brazilian patients with chronic myelopathies of undetermined origin. Neste relato preliminar os autores registram a constatação de alta prevalência de soropositividade para anticorpos dirigidos ao HTLV-I detectados pelo método de Western-blot (37,5%) em amostra de 16 pacientes brasileiros com mielopatias crônicas de causa não determinada.